We are a clinical-stage biotechnology company uniquely positioned to advance next-generation potentially curative cell therapies for cancer patients. (Incorporated in Delaware) Our programs, platform technologies and manufacturing strategy are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is a protein that has been engineered to modify T cells so they […]

(Note: Metros  Development withdrew its previous IPO plans in an SEC letter dated July 16, 2024, and subsequently filed a new F-1 on July 16, 2024 – at the suggestion of the regulators – to reveal the terms for a larger IPO with a new sole book-runner. Metros Development also said it would seek to […]

We are a global specialty insurance and reinsurance company founded in Bermuda in 2013. (Incorporated in Bermuda) We harness multiple drivers to create shareholder value. These include diverse underwriting operations supported by proprietary technology and a team of over 500 full-time employees, a strong balance sheet, and a unique investment management relationship with Two Sigma […]

We provide cloud-based payments software for healthcare providers to help them manage their revenue. (Incorporated in Delaware)  Our mission is to simplify healthcare payments through our modern cloud-based software, enabling our healthcare clients to prioritize patient care and optimize their financial performance. Overview Waystar provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. […]

We are a holding company incorporated in the British Virgin Islands. Our principal Hong Kong subsidiary, mFINANCE Limited, provides an online trading platform for the Asian market. This is known as a Platform as a Service (PaaS). (Incorporated in the British Virgin Islands) m-FINANCE has approximately 20 years of experience providing real-time mission critical forex, […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from Euronext Paris. This is a public offering of American Depositary Shares in the U.S. and a private placement of ordinary shares in France and elsewhere in Europe.) We are a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory […]

We are a Phase 1 clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. (Incorporated in Delaware) Our clinical focus is to selectively target the sodium ion-channel known as “NaV1.7”, as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology. […]

We operate tea gardens in China. Primarily processed white tea is our leading product. (incorporated in the Cayman Islands) We are an integrated supplier of tea products in mainland China. Our major tea products include (i) primarily-processed tea consisting of white tea and black tea, and (ii) refined white tea and black tea. “Primarily-processed tea” refers to fresh tea leaves […]

Note: This is NOT an IPO. This is a reverse IPO. This deal is also a unit offering of stock and warrants. A reverse IPO is also known as a reverse takeover, according to the Corporate Finance Institute, which defines it as “the process in which a small private company goes public by acquiring a […]

We are a leading digital transformation enabler in the small and medium enterprise, or the SME segment of the e-commerce enablement and digital optimizing services market in Singapore. We offer business and technology solutions which are designed to optimize our clients’ experiences with their customers by driving digital adoption and self-service. (Incorporated in the Cayman Islands) We […]